Wishful thinking, dude. This is what the professionals call a "dead cat bounce." Selling will continue down to its cash backing. Nexavar has stolen all the turf.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025